share_log

Morgan Stanley Maintains Equal-Weight on Phibro Animal Health, Lowers Price Target to $16

Morgan Stanley Maintains Equal-Weight on Phibro Animal Health, Lowers Price Target to $16

摩根士丹利对Phibro动物健康保持同等权重,将目标股价下调至16美元
Benzinga ·  2023/11/09 09:32

Morgan Stanley analyst Erin Wright maintains Phibro Animal Health (NASDAQ:PAHC) with a Equal-Weight and lowers the price target from $17 to $16.

摩根士丹利分析师艾琳·赖特维持辉宝动物健康(纳斯达克股票代码:PAHC)的权重持平,并将目标股价从17美元下调至16美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发